Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

If your centre would like to recruit participants to Add-Aspirin, contact us:

Page last updated on 24-06-2016